InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Friday, 07/09/2021 3:59:49 PM

Friday, July 09, 2021 3:59:49 PM

Post# of 198060
ENZC and INTEL ( INTC)

exciting new developments at the company that have been met with some skepticism have been verified by a joint whitepaper between Enzolytics and Fortune 500 company Intel (NASDAQ: INTC).

Enzolytics, on the other hand, has already developed its HIV therapeutic ITV-1 which has proven efficacy in a phase 3 (late stage) trial, and is using AI through its subsidiary BioClonetics to develop antibody cocktails on immutable sites on various viruses. Thus, as BioClonetics is pursuing discovery of additional antibodies for COVID-19, HIV, and other diseases through AI, and it has a collaboration with giant Intel, and already has viable products for COVID-19 and HIV, it could roughly be worth twice as much, or $400 million. This is ignoring the company’s prior work in producing antibodies for rabies, influenza A, influenza B, tetanus, and diphtheria.


excellent article here is the link:

https://insiderfinancial.com/enzolytics-enzc-working-with-intel-intc/181517/

I don't call people names or use vulgar language in Public or Private. Once you cuss and call someone names you lost the argument and also lost your class. You have nothing else left to defend your comment. Statements are my Opinion only. Do your own DD.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News